» Articles » PMID: 29070016

Investigating the Epigenetic Profile of the Inflammatory Gene IL-6 in Late-life Depression

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2017 Oct 27
PMID 29070016
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is well established that there is a link between inflammation and depression, with several studies reporting increased circulating levels of the pro-inflammatory cytokine, interleukin-6 (IL6), in depressed individuals. Peripheral epigenetic marks, including DNA methylation, hold promise as biomarkers for a range of complex conditions, with potential to inform diagnosis and tailor interventions. The aim of this study was to determine whether individuals with depression display differential methylation of the IL6 gene promoter compared to individuals without depression.

Methods: The ESPRIT study of later life neuropsychiatric disorders used a random sampling framework to select non-institutionalised participants aged ≥65 years and over living in the Montpellier region of France. Major depressive disorder (MDD) was assessed using the Mini International Neuropsychiatric Interview (MINI) according to DSM-IV criteria. High levels of depressive symptoms were defined as a score of ≥16 on the Centre for Epidemiologic Studies Depression Scale (CES-D). IL6 promoter DNA methylation was measured on a sub-sample of 380 participants who provided buccal samples.

Results: Individuals with depression (current MDD or high depressive symptoms) had lower IL6 methylation levels at one of the four sites investigated, however the effect size was small (∆ 2.4%, SE 0.009, p = 0.006). Interestingly, antidepressant use was independently associated with higher IL-6 methylation at the same site (∆ 4.6%, SE 0.019, p = 0.015). In multivariate linear regression analyses adjusting for covariates, including sex and smoking status, these associations remained. There was no effect modification when considering IL6 genotype.

Conclusion: This study presents evidence that IL6 methylation may be a marker of depression status in older individuals, however further work is now needed to replicate these findings and to assess the association with inflammatory status of individuals.

Citing Articles

Pharmaco-Multiomics: A New Frontier in Precision Psychiatry.

Dhieb D, Bastaki K Int J Mol Sci. 2025; 26(3).

PMID: 39940850 PMC: 11816785. DOI: 10.3390/ijms26031082.


Epigenetic mechanisms of rapid-acting antidepressants.

Inserra A, Campanale A, Rezai T, Romualdi P, Rubino T Transl Psychiatry. 2024; 14(1):359.

PMID: 39231927 PMC: 11375021. DOI: 10.1038/s41398-024-03055-y.


Gut Microbiota Dysbiosis and Inflammation Dysfunction in Late-Life Depression: An Observational Cross-Sectional Analysis.

Chen Y, Le D, Xu J, Jin P, Zhang Y, Liao Z Neuropsychiatr Dis Treat. 2024; 20:399-414.

PMID: 38436041 PMC: 10908248. DOI: 10.2147/NDT.S449224.


Relationship between physical activity and cerebral white matter hyperintensity volumes in older adults with depressive symptoms and mild memory impairment: a cross-sectional study.

Otsuka S, Kikuchi K, Takeshita Y, Takada S, Tani A, Sakakima H Front Aging Neurosci. 2024; 16:1337397.

PMID: 38414630 PMC: 10896982. DOI: 10.3389/fnagi.2024.1337397.


Associations between serum estradiol and IL-6/sIL-6R/sgp130 complex in female patients with major depressive disorder.

Sun T, Chen Q, Mei J, Li Y BMC Psychiatry. 2023; 23(1):742.

PMID: 37828513 PMC: 10568828. DOI: 10.1186/s12888-023-05248-z.


References
1.
Coolen M, Statham A, Gardiner-Garden M, Clark S . Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res. 2007; 35(18):e119. PMC: 2094090. DOI: 10.1093/nar/gkm662. View

2.
Lolak S, Suwannarat P, Lipsky R . Epigenetics of depression. Prog Mol Biol Transl Sci. 2014; 128:103-37. DOI: 10.1016/B978-0-12-800977-2.00005-X. View

3.
Ritchie K, Artero S, Beluche I, Ancelin M, Mann A, Dupuy A . Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry. 2004; 184:147-52. DOI: 10.1192/bjp.184.2.147. View

4.
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin J, Humphries S . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7):1369-76. PMC: 508984. DOI: 10.1172/JCI2629. View

5.
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H . Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1998; 9(11):853-8. DOI: 10.1006/cyto.1997.0238. View